Skip to content

Douglas API

Just another WordPress site

Clinicians China licenced to HTDK Pharmaceuticals

Published 3 October 2022
Categorized as Uncategorised

New Zealand’s largest medical R&D facility opens in West Auckland

Published 15 September 2022
Categorized as Commercial

Trial data suggests major breakthrough in Treatment Resistant Depression

Published 17 June 2021
Categorized as Research

Douglas works with 75 year old inventor to create easy to us spray pump for those with arthritis

Published 23 April 2020
Categorized as Large Dispensers

Douglas wins Best Large Business in the New Zealand International Business Awards

NZIB
Published 7 November 2019
Categorized as Awards

Douglas Pharmaceutical’s Chief Scientific Officer talks about a new drug for treatment resistant depression

RISE
Published 28 May 2019
Categorized as Large Dispensers

Douglas Pharmaceuticals begins work on $35MM Research and Development building

Published 23 April 2019
Categorized as Commercial

Douglas Pharmaceuticals tackles treatment-resistant depression

Published 22 January 2019
Categorized as Research

New Zealand children to benefit from $9 million gift to Starship

New Zealand children to benefit from $9 million gift to Starship
New Zealand children to benefit from $9 million gift to Starship
Published 6 December 2018
Categorized as Corporate Responsibility

Douglas wins ‘Inspiring Team Leadership’ award

Published 9 November 2018
Categorized as Awards

Posts navigation

Page 1 Page 2 Older posts

Recent Posts

  • Clinicians China licenced to HTDK Pharmaceuticals
  • New Zealand’s largest medical R&D facility opens in West Auckland
  • Trial data suggests major breakthrough in Treatment Resistant Depression
  • Douglas works with 75 year old inventor to create easy to us spray pump for those with arthritis
  • Douglas wins Best Large Business in the New Zealand International Business Awards

Recent Comments

No comments to show.
Douglas API
Proudly powered by WordPress.